Skip to main content
Clinical Trials/NCT05150847
NCT05150847
Unknown
Not Applicable

The Effect of Prone Positioning on Oxygenation and Respiratory Mechanics in Patients With COVID-19 Pneumonia

Tepecik Training and Research Hospital1 site in 1 country50 target enrollmentDecember 25, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronavirus Disease 2019
Sponsor
Tepecik Training and Research Hospital
Enrollment
50
Locations
1
Primary Endpoint
Oxygenation
Last Updated
4 years ago

Overview

Brief Summary

Prone positioning improves oxygenation in patients with ARDS (1-3). Patients with severe ARDS due to COVID-19 are candidates for prone position. It should be started within 36-48 h and maintained 1, 3). Prone ventilationARDS based on a randomized trial that showed a mortality benefit (PROSEVA) (3).

The improvement of oxygenation occurs by making ventilation more homogeneous, limiting ventilator-associated lung injury (4-6).

Prone positioning was as effective in improving oxygenation, static respiratory system compliance (Crs) (7).

Higher PEEP should be applied when there is a high recruitability potential of the lung. This study aimed to investigate whether prone positioning changes the recruitability position of the lung.in COVID-ARDS.

Detailed Description

Prone positioning improves oxygenation in patients with ARDS (1-3). Patients with severe ARDS due to COVID-19 are candidates for prone position. It should be started within 36-48 h and maintained 1, 3). Prone ventilationARDS based on a randomized trial that showed a mortality benefit (PROSEVA) (3). The improvement of oxygenation occurs by making ventilation more homogeneous, limiting ventilator-associated lung injury (4-6). Prone positioning was as effective in improving oxygenation, static respiratory system compliance (Crs) (7).Higher PEEP should be applied when there is a high recruitability potential of the lung. This study aimed to investigate whether prone positioning changes the oxygenation, respiratory mechanics and recruitability position of the lung in COVID-ARDS.

Registry
clinicaltrials.gov
Start Date
December 25, 2021
End Date
April 13, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Tepecik Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Kazim Rollas

Intensive Care Specialist, Principal Investigator

Tepecik Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Adult patients with laboratory-confirmed COVID-19 admitted to the ICU
  • The patients receive invasive mechanical ventilation and meet the criteria for ARDS (Berlin definition) (8), with under continuous infusion of sedatives,

Exclusion Criteria

  • Pregnancy
  • Pneumothorax and or chest tube
  • Chronic obstructive lung disease
  • interstitial lung disease
  • intraabdominal hypertension
  • increase in intracranial blood pressure
  • Haemodynamic unstability requiring vasopressors

Outcomes

Primary Outcomes

Oxygenation

Time Frame: intubation + 48 hours

PaO2/FiO2

Secondary Outcomes

  • Static compliance(intubation + 48 hours)
  • Recruitability(intubation + 48 hours)

Study Sites (1)

Loading locations...

Similar Trials